PROCTER & GAMBLE HEALTH | CAPLIN POINT | PROCTER & GAMBLE HEALTH/ CAPLIN POINT |
|||
---|---|---|---|---|---|
P/E (TTM) | x | 34.5 | 23.0 | 150.2% | View Chart |
P/BV | x | 10.5 | 5.4 | 193.7% | View Chart |
Dividend Yield | % | 2.0 | 0.3 | 597.9% |
PROCTER & GAMBLE HEALTH CAPLIN POINT |
EQUITY SHARE DATA | |||||
---|---|---|---|---|---|
PROCTER & GAMBLE HEALTH Jun-23 |
CAPLIN POINT Mar-23 |
PROCTER & GAMBLE HEALTH/ CAPLIN POINT |
5-Yr Chart Click to enlarge
|
||
High | Rs | 5,366 | 856 | 626.8% | |
Low | Rs | 3,883 | 575 | 675.3% | |
Sales per share (Unadj.) | Rs | 740.7 | 193.2 | 383.3% | |
Earnings per share (Unadj.) | Rs | 138.2 | 49.7 | 278.3% | |
Cash flow per share (Unadj.) | Rs | 155.2 | 55.6 | 279.1% | |
Dividends per share (Unadj.) | Rs | 95.00 | 4.50 | 2,111.1% | |
Avg Dividend yield | % | 2.1 | 0.6 | 326.6% | |
Book value per share (Unadj.) | Rs | 447.6 | 245.7 | 182.2% | |
Shares outstanding (eoy) | m | 16.60 | 75.90 | 21.9% | |
Bonus / Rights / Conversions | 0 | 0 | - | ||
Price / Sales ratio | x | 6.2 | 3.7 | 168.6% | |
Avg P/E ratio | x | 33.5 | 14.4 | 232.2% | |
P/CF ratio (eoy) | x | 29.8 | 12.9 | 231.6% | |
Price / Book Value ratio | x | 10.3 | 2.9 | 354.8% | |
Dividend payout | % | 68.7 | 9.1 | 758.5% | |
Avg Mkt Cap | Rs m | 76,761 | 54,308 | 141.3% | |
No. of employees | `000 | NA | NA | - | |
Total wages/salary | Rs m | 2,062 | 1,361 | 151.5% | |
Avg. sales/employee | Rs Th | 0 | 0 | - | |
Avg. wages/employee | Rs Th | 0 | 0 | - | |
Avg. net profit/employee | Rs Th | 0 | 0 | - |
INCOME DATA | |||||
---|---|---|---|---|---|
Net Sales | Rs m | 12,296 | 14,667 | 83.8% | |
Other income | Rs m | 184 | 565 | 32.5% | |
Total revenues | Rs m | 12,480 | 15,233 | 81.9% | |
Gross profit | Rs m | 3,247 | 4,406 | 73.7% | |
Depreciation | Rs m | 281 | 450 | 62.5% | |
Interest | Rs m | 8 | 8 | 98.7% | |
Profit before tax | Rs m | 3,142 | 4,514 | 69.6% | |
Minority Interest | Rs m | 0 | 0 | - | |
Prior Period Items | Rs m | 0 | 0 | - | |
Extraordinary Inc (Exp) | Rs m | 0 | 0 | - | |
Tax | Rs m | 847 | 744 | 113.9% | |
Profit after tax | Rs m | 2,295 | 3,770 | 60.9% | |
Gross profit margin | % | 26.4 | 30.0 | 87.9% | |
Effective tax rate | % | 27.0 | 16.5 | 163.7% | |
Net profit margin | % | 18.7 | 25.7 | 72.6% |
BALANCE SHEET DATA | |||||
---|---|---|---|---|---|
Current assets | Rs m | 11,713 | 15,545 | 75.3% | |
Current liabilities | Rs m | 6,791 | 2,680 | 253.4% | |
Net working cap to sales | % | 40.0 | 87.7 | 45.6% | |
Current ratio | x | 1.7 | 5.8 | 29.7% | |
Inventory Days | Days | 263 | 70 | 374.8% | |
Debtors Days | Days | 343 | 10 | 3,502.6% | |
Net fixed assets | Rs m | 10,617 | 6,231 | 170.4% | |
Share capital | Rs m | 166 | 898 | 18.5% | |
"Free" reserves | Rs m | 7,265 | 17,754 | 40.9% | |
Net worth | Rs m | 7,431 | 18,651 | 39.8% | |
Long term debt | Rs m | 0 | 0 | - | |
Total assets | Rs m | 22,330 | 21,776 | 102.5% | |
Interest coverage | x | 409.1 | 579.7 | 70.6% | |
Debt to equity ratio | x | 0 | 0 | - | |
Sales to assets ratio | x | 0.6 | 0.7 | 81.8% | |
Return on assets | % | 10.3 | 17.3 | 59.4% | |
Return on equity | % | 30.9 | 20.2 | 152.8% | |
Return on capital | % | 42.4 | 24.2 | 174.9% | |
Exports to sales | % | 0 | 32.8 | 0.0% | |
Imports to sales | % | 13.1 | 1.7 | 788.1% | |
Exports (fob) | Rs m | NA | 4,804 | 0.0% | |
Imports (cif) | Rs m | 1,605 | 243 | 660.7% | |
Fx inflow | Rs m | 1,465 | 4,804 | 30.5% | |
Fx outflow | Rs m | 1,605 | 243 | 660.7% | |
Net fx | Rs m | -140 | 4,561 | -3.1% |
CASH FLOW | |||||
---|---|---|---|---|---|
From Operations | Rs m | 2,360 | 2,714 | 87.0% | |
From Investments | Rs m | -215 | -2,176 | 9.9% | |
From Financial Activity | Rs m | -985 | -282 | 349.6% | |
Net Cashflow | Rs m | 1,160 | 268 | 432.9% |
Indian Promoters | % | 0.0 | 70.6 | - | |
Foreign collaborators | % | 51.8 | 0.0 | - | |
Indian inst/Mut Fund | % | 20.0 | 4.4 | 450.8% | |
FIIs | % | 6.2 | 3.3 | 188.0% | |
ADR/GDR | % | 0.0 | 0.0 | - | |
Free float | % | 48.2 | 29.4 | 164.0% | |
Shareholders | 56,778 | 81,409 | 69.7% | ||
Pledged promoter(s) holding | % | 0.0 | 0.0 | - |
Compare PROCTER & GAMBLE HEALTH With: DIVIS LABORATORIES CIPLA SUN PHARMA DR. REDDYS LAB MANKIND PHARMA
No comparison is complete without understanding how the stock prices have performed over a period of time.
Here's a brief comparison:
Period | Procter & Gamble Health | CAPLIN POINT | S&P BSE HEALTHCARE |
---|---|---|---|
1-Day | 0.23% | -0.03% | -0.57% |
1-Month | -1.43% | 6.18% | 0.07% |
1-Year | 0.31% | 103.31% | 52.18% |
3-Year CAGR | -9.37% | 38.01% | 14.04% |
5-Year CAGR | 4.58% | 28.70% | 19.13% |
* Compound Annual Growth Rate
Here are more details on the Procter & Gamble Health share price and the CAPLIN POINT share price.
Moving on to shareholding structures...
The promoters of Procter & Gamble Health hold a 51.8% stake in the company. In case of CAPLIN POINT the stake stands at 70.6%.
To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of Procter & Gamble Health and the shareholding pattern of CAPLIN POINT.
Finally, a word on dividends...
In the most recent financial year, Procter & Gamble Health paid a dividend of Rs 95.0 per share. This amounted to a Dividend Payout ratio of 68.7%.
CAPLIN POINT paid Rs 4.5, and its dividend payout ratio stood at 9.1%.
You may visit here to review the dividend history of Procter & Gamble Health, and the dividend history of CAPLIN POINT.
For a sector overview, read our pharmaceuticals sector report.
After opening the day on high, Indian share markets continued the momentum as the session progressed and ended the higher.